| Product Code: ETC12838831 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Influenza Vaccines Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Influenza Vaccines Market - Industry Life Cycle |
3.4 Israel Influenza Vaccines Market - Porter's Five Forces |
3.5 Israel Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Israel Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.7 Israel Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Israel Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Israel Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination |
4.2.2 Rising prevalence of influenza cases in Israel |
4.2.3 Government initiatives promoting vaccination programs |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High cost associated with influenza vaccines |
4.3.3 Vaccine hesitancy among certain population groups |
5 Israel Influenza Vaccines Market Trends |
6 Israel Influenza Vaccines Market, By Types |
6.1 Israel Influenza Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Influenza Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Israel Influenza Vaccines Market Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031F |
6.1.4 Israel Influenza Vaccines Market Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031F |
6.1.5 Israel Influenza Vaccines Market Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031F |
6.2 Israel Influenza Vaccines Market, By Strain Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Influenza Vaccines Market Revenues & Volume, By Trivalent Vaccines, 2021 - 2031F |
6.2.3 Israel Influenza Vaccines Market Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031F |
6.3 Israel Influenza Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Israel Influenza Vaccines Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Israel Influenza Vaccines Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Israel Influenza Vaccines Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Israel Influenza Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Influenza Vaccines Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.3 Israel Influenza Vaccines Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
7 Israel Influenza Vaccines Market Import-Export Trade Statistics |
7.1 Israel Influenza Vaccines Market Export to Major Countries |
7.2 Israel Influenza Vaccines Market Imports from Major Countries |
8 Israel Influenza Vaccines Market Key Performance Indicators |
8.1 Number of vaccinations administered annually |
8.2 Percentage of population vaccinated against influenza |
8.3 Rate of influenza-related hospitalizations and deaths |
9 Israel Influenza Vaccines Market - Opportunity Assessment |
9.1 Israel Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Israel Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
9.3 Israel Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Israel Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Israel Influenza Vaccines Market - Competitive Landscape |
10.1 Israel Influenza Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Israel Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here